Live Breaking News & Updates on Silvia vidal

Stay informed with the latest breaking news from Silvia vidal on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Silvia vidal and stay connected to the pulse of your community

Study show extracellular vesicles exchange genetic information between cells in the sea

Study show extracellular vesicles exchange genetic information between cells in the sea
phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.

North-sea , Oceans-general- , Oceans , Susanne-erdmann , Silvia-vidal , Max-planck-research-group-archaea-virology , Max-planck-institute-for-marine-microbiology , Max-planck-institute-in-bremen , Max-planck-institute , North-sea-island , Marine-microbiology ,

Nanotech and Machine Learning Platform Rapidly Detects Infectious Diseases

Nanotech and Machine Learning Platform Rapidly Detects Infectious Diseases
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Canada , Dao-nguyen , Chen-liang , Mahsa-jalali , Silvia-vidal-at-mcgill-university , Canada-research , Mcgill-university-professor-of-bioengineering-sara-mahshid , Sara-mahshid-lab , Mcgill-university-professor , Bioengineering-sara-mahshid , Tamer-abdel-fatah , Canada-research-chair

McGill and RI-MUHC awarded $5.1 million for infectious disease research

A new grant from the Canadian Foundation for Innovation will invest in leading-edge Containment Level 3 facilities and personnel New funding of $5.1 million from the Canadian Foundation for Innovation (CFI), announced today by the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, will help researchers Marcel Behr, MD, PhD, and Silvia Vidal, PhD, ensure that Canada is better prepared for the next pandemic. This funding is part of the more than $127 million investment being made through the CFI to support upgrades to eight biocontainment facilities across the country as part of its new Biosciences Research Infrastructure Fund (BRIF) program. The investments received under the BRIF program will enable expansion of the research capacity of Containment Level 3 (CL3) laboratories at McGill and the Research Institute of the McGill University Health Centre (RI-MUHC). These labs are equipped to study Risk Group 3 (RC3) pathogens, including SARS-CoV-2. The funds will enable the acquisition of new infrastructure and facilitate the training of the next generation of infectious disease research specialists. “Preparing for the next pandemic means building the capacity to safely and securely study the pathogenic microorganisms that cause epidemic and pandemic diseases,” says Dr. Behr, senior scientist in the RI-MUHC’s Infectious Diseases and Immunity in Global Health (IDIGH) Program and Director of the McGill Interdisciplinary Initiative in Infection and Immunity (MI4). “This new funding ensures that our CL3 facilities will be better equipped for the study of Risk Group 3 pathogens, which include the SARS-CoV-2 virus, Tuberculosis (TB), and emerging infections such as H5N1 and H7N9.” In announcing the funding, CFI President and CEO Roseann O’Reilly Runte, notes that, “The COVID-19 pandemic clearly demonstrated the importance of cutting-edge research in infectious diseases. Ensuring labs meet standards and are well equipped to combat new challenges in biosciences will contribute to a healthy future for Canadians.” “Demand for CL3 facilities spiked with the arrival of the COVID-19 pandemic, and continues to rise,” adds McGill Professor Vidal, who is also an investigator in the IDIGH program at the RI-MUHC. “In both our CL3 locations, McGill and RI-MUHC investigators, affiliated collaborators, and external companies are working on a range of projects to learn more about the SARS-CoV-2 virus and other Risk Group 3 pathogens. This funding will allow our facilities to safely and effectively support the large number of high quality studies that are being proposed.” In presenting their proposal for funding, the researchers also emphasized the importance of training the next generation of researchers in microbiology, immunology and the expertise needed to work in CL3 laboratories. “We will develop the next generation of highly qualified personnel, including investigators to characterize the next pandemic virus; technologists to test new drugs; the skilled personnel to evaluate new vaccines; and the facility personnel to ensure that the labs are safe, with pathogens contained and findings disseminated to the public and private stakeholders,” says Dr. Behr. About McGill University Founded in Montreal, Quebec, in 1821, McGill University is Canada’s top ranked medical doctoral university. McGill is consistently ranked as one of the top universities, both nationally and internationally. It is a world-renowned institution of higher learning with research activities spanning three campuses, 11 faculties, 13 professional schools, 300 programs of study and over 39,000 students, including more than 10,400 graduate students. McGill attracts students from over 150 countries around the world, its 12,000 international students making up 30% of the student body. Over half of McGill students claim a first language other than English, including approximately 20% of our students who say French is their mother tongue. http://www.mcgill.ca/newsroom/ http://twitter.com/McGillU

Montreal , Quebec , Canada , France , French , Canadians , Canadian , Silvia-vidal , Marcel-behr , Roseann-oreilly-runte , Immunity-in-global-health , Biosciences-research-infrastructure-fund

RI-MUHC and McGill awarded $5.1 million for infectious disease research | McGill University Health Centre

A new grant from the Canadian Foundation for Innovation will invest in leading-edge Containment Level 3 facilities and personnel SOURCE: RI-MUHC and McGill FMHS Sneak peak in the RI-MUHC CL3 platform

Canada , Canadians , Canadian , Silvia-vidal , Marcel-behr , Roseann-oreilly-runte , Immunity-in-global-health , Biosciences-research-infrastructure-fund , Mcgill-interdisciplinary-initiative-in-infection , Canadian-foundation-for-innovation , Risk-group , Canadian-foundation

$10,000 in Grants Available for Women Alpinists; Act Fast

GRIT&ROCK makes $10,000 in grant funding available to women alpinists or female-led climbing teams worldwide. Applications are due soon.

Canada , Pakistan , Nepal , Silvia-vidal , Camilo-rada , Masha-gordon , Ralf-dujmovits , Natalia-martinez , Nancy-hansen , Facebook , First-ascent-expedition-prize , Ascent-expedition-prize

The Definitive Guide to Climbing Jargon

If you're cruxing out on climbing vocab, check out GearJunkie's guide to the jargon — from gripping onsights to jingus gear and more.

United-states , United-kingdom , Ten-sleep , Wyoming , Peak-district , Derbyshire , Redpoint , Highland , Switzerland , Spain , Utah , Spanish

Silvia Vidal's Exceptional Solo Aid Climbing Style: 'I'll Go Alone. I Am Alone.'

'If I go alone, I am alone.' Few, if any, climbers embody that idea like Silvia Vidal. Her aid solo climbing has garnered Piolet d'Or attention.

India , El-capitan , Silvia-vidal , Cerro-chileno-grande , Silvia-vidal-el , Vidal-el-cap , Chileno-grande , Cerro-chileno , Arrigetch-peaks , Aid-climbing ,

Alpine Achievement Awards, 2 High-Risk Ultras, and a Few More Stories to Start Your Week

A short and sweet weekly wrap-up of top news in exploration and adventure. Here’s what you missed, and a few things to look forward to.

Russia , Bears-ears , Utah , United-states , Kenya , Netherlands , Tatarstan , Morocco , Belgium , Cedar-mesa , Boston , Massachusetts

La "autocita" se estrenó de forma fallida para 574 Erasmus de Vigo

La "autocita" se estrenó de forma fallida para 574 Erasmus de Vigo
close
M.B.
M.B.
05/jul./21
El servicio de autocita del Sergas se estrenó entre dudas y dificultades por parte de los 574 estudiantes de la UVigo que realizarán un Erasmus el próximo curso, los primeros que en poder acceder a este sistema para solicitar la vacunación. Sin embargo, los jóvenes que ayer intentaron utilizar este nuevo servicio no pudieron registrar sus citas ni desde la página web ni la aplicación Sergas Móbil.
Fue el caso de Silvia Vidal, estudiante de Fisioterapia en la UVigo que ayer intentó conseguir cita para vacunarse desde primera hora ya que es un requisito para poder irse a estudiar a Polonia. “Ya nos habían pedido el certificado de vacunación y estuve toda la mañana probando pero no hubo manera, nos facilitaron un número al que llamar pero a mí no me cogieron el teléfono y a un compañero le indicaron que hasta el día 8 no funcionará”. afirma. Desde el Sergas señalan que la plataforma continúa en pruebas y se pondrá en marcha de forma progresiva. Lo mismo le ocurrió a Paula Cavaleiro, viguesa que estudia Periodismo y Comunicación Audiovisual en Madrid y que el próximo año irá a Inglaterra. Además, al llamar para preguntar por qué no estaba operativo le comunicaron que aunque se encuentre en Vigo, solo podrán pedir cita los vacunados en las universidades gallegas. “No me parece lógico que vaya por Universidades y no por comunidades”, asegura.

Poland , Madrid , Spain , Silvia-vidal , Journalism-and-avms , Opinion-of-the-students , போல்யாஂட் , மாட்ரிட் , ஸ்பெயின் , சில்வியா-விடல் ,

Consejos para organizar nuestra economía para la campaña escolar

Consejos para organizar nuestra economía para la campaña escolar
chimbotenlinea.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chimbotenlinea.com Daily Mail and Mail on Sunday newspapers.

Chimbote , Ancash , Peru , Silvia-vidal , Bank-or , பெரு , சில்வியா-விடல் , வங்கி-அல்லது ,